244 related articles for article (PubMed ID: 4602058)
21. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
Wycis HT
Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
[No Abstract] [Full Text] [Related]
22. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
23. [Psychic manifestations during treatment of Parkinson's disease with L-dopa].
Bonduelle M
Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897
[No Abstract] [Full Text] [Related]
24. A year's experience of L-DOPA in the treatment of Parkinson's disease.
Guidetti B; Giuffrè R
Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
[No Abstract] [Full Text] [Related]
25. [Piribedil in the treatment of Parkinson disease (author's transl)].
Nardini M; Sciannandrone R; Fieschi C; De Simone G
Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998
[TBL] [Abstract][Full Text] [Related]
26. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
[No Abstract] [Full Text] [Related]
27. [Clinical study of L-dopa in Parkinson's disease].
Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
[No Abstract] [Full Text] [Related]
28. Treatment of parkinsonism with levodopa.
Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
[No Abstract] [Full Text] [Related]
29. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
[No Abstract] [Full Text] [Related]
30. Treatment failures with L-dopa in Parkinsonism.
Julsrud OJ
Acta Neurol Scand Suppl; 1972; 51():123-4. PubMed ID: 4514337
[No Abstract] [Full Text] [Related]
31. Parkinson's disease: a clinical review.
Lieberman AN
Am J Med Sci; 1974 Feb; 267(2):66-80. PubMed ID: 4821328
[No Abstract] [Full Text] [Related]
32. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
Sugita K; Mutsuga N; Takaoka Y; Takeda A
No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
[No Abstract] [Full Text] [Related]
33. A quantitative evaluation of the effects of L-dopa on Parkinson's disease.
Velasco F; Velasco M
Neuropharmacology; 1973 Feb; 12(2):89-99. PubMed ID: 4595553
[No Abstract] [Full Text] [Related]
34. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
Almici GM; Sbarbaro V
Minerva Med; 1974 Feb; 65(8):398-401. PubMed ID: 4820722
[No Abstract] [Full Text] [Related]
35. [Outcome of Parkinsonism after two years of levodopa plus R04-4602 (author's transl)].
Faglioni P; Gasparini M; Spinnler H
Riv Patol Nerv Ment; 1975; 96(4):270-86. PubMed ID: 785578
[TBL] [Abstract][Full Text] [Related]
36. [The treatment of Parkinson's syndrome with L-dopa].
Völler GW; Kerstan J
Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
[No Abstract] [Full Text] [Related]
37. [Indications and results of monoamine treatment in parkinsonian syndromes].
Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464
[No Abstract] [Full Text] [Related]
38. [10 years of L-DOPA therapy of Parkinson's syndrome].
Birkmayer W
Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
[No Abstract] [Full Text] [Related]
39. Parkinson's disease treated with L-dopa. Three-year follow-up report.
Mones RJ
N Y State J Med; 1972 Nov; 72(22):2749-50. PubMed ID: 4510706
[No Abstract] [Full Text] [Related]
40. [Study of L-dopa treatment and its principal side effects in aged subjects].
Antonini F; Baroni A; Bucalossi A; Roveyaz L
Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
